GlassScriptPhysician profile
Derek Andrew Ballas
NPI 1164789780
$758.13
in general payments reported to CMS, 2019-2025
13 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.98 · 2020: $46.99 · 2021: $14.01 · 2022: $35.17 · 2023: $355 · 2024: $44.96 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $161.10 | 2023 | Myfembree |
| Boston Scientific Corporation | $152.94 | 2023 | Solyx Sis System |
| Ethicon US, LLC | $135.42 | 2024-2025 | Vistaseal, Evarrest, Dermabond |
| Abbvie INC. | $91.53 | 2019-2022 | |
| Baxter Healthcare | $41.33 | 2023 | Adept |
| Coopersurgical, INC. | $29.69 | 2019-2025 | Paragard T 380a |
| Organon LLC | $29.07 | 2021-2022 | |
| Sage Therapeutics, LLC | $28.88 | 2025 | Zurzuvae |
| Convatec INC. | $22.26 | 2024 | |
| Lupin INC. | $18.37 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.98 | 2025 | |
| Minerva Surgical, INC | $15.73 | 2025 | |
| Amag Pharmaceuticals, INC. | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Ballas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.